or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    FUSN A Fusion Pharmaceuticals Inc. 0.09
    CGEM A Cullinan Management, Inc. 31.43
    ALXO A ALX Oncology Holdings Inc. -0.06
    STTK A Shattuck Labs, Inc. 8.28
    XOMA A XOMA Corporation 0.20
    TCRX A TScan Therapeutics, Inc. 0.41
    SLS B SELLAS Life Sciences Group, Inc. -3.95
    CRIS B Curis, Inc. -0.34
    MRUS B Merus N.V. 0.24
    HOWL B Werewolf Therapeutics, Inc. 8.70
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Shell Companies
    Related Stock Lists: Biopharmaceutical Cancer Biotechnology Medicine Clinical Medicine Hematologic Malignancies Oncology Acute Leukemia Advanced Solid Tumors Biology Cancer Immunotherapy Cancer Treatment Checkpoint Inhibitor Immune System Immunotherapy Inflammation Lymphoma Morpholines Sarcoma Signal Transduction

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    GERM D ETFMG Treatments Testing and Advancements ETF 1.77
    LABD B Direxion Daily S&P Biotech Bear 3X Shares 0.96
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 0.38
    WDNA D WisdomTree BioRevolution Fund 0.35
    SDD B ProShares UltraShort SmallCap600 0.31
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare GERM to BBC Compare LABD to WDNA Compare WDNA to SDD

        Solid Tumors Stocks Recent News

        Date Stock Title
        Apr 27 CGEM Amgen’s Blincyto data send Cullinan higher
        Apr 26 CGEM Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
        Apr 26 FUSN Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
        Apr 26 FUSN Top 4 Health Care Stocks That May Plunge This Month
        Apr 26 MRUS Merus (MRUS) Moves 7.1% Higher: Will This Strength Last?
        Apr 25 FUSN Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
        Apr 25 MRUS Will Merus N.V. (MRUS) Report Negative Q1 Earnings? What You Should Know
        Apr 25 XOMA XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
        Apr 24 CGEM Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
        Apr 24 TCRX TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
        Apr 24 TCRX TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
        Apr 24 CGEM Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
        Apr 24 HOWL Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
        Apr 24 ALXO ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
        Apr 24 MRUS Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
        Apr 24 XOMA Actym Therapeutics Appoints Thomas Smart as CEO
        Apr 23 FUSN Fusion Pharmaceuticals Inc. (FUSN) Ascends But Remains Behind Market: Some Facts to Note
        Apr 23 XOMA Day One wins FDA nod for brain cancer therapy, Ojemda
        Apr 23 HOWL Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
        Apr 22 TCRX TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Shell Companies
        Related Stock Lists: Medicine Biopharmaceutical Cancer Biotechnology Breast Cancer Immune System Acid Antibodies Clinical Medicine Drugs Immunology Immunotherapy Lymphoma Monoclonal Antibody Oncology Pharmaceutical Treatment Of Breast Cancer Vaccination Acute Kidney Injury Acute Myeloid Leukemia
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags